Discovery Genomics has spent years optimizing our proprietary workflow, developing robust processes that include a method for dual extraction of RNA and DNA from FFPE tissues that delivers higher quality and quantities of RNA without negatively impacting DNA quality and quantity.
Colorectal and Lung Tumoroids are Now Available
NEW Blog Post - Progressing Ex Vivo Gene Editing Innovations with High-Quality Leukopaks
Learn More about Discovery's AI-Annotated FFPE Tissues and DiscoverAI Tissue Analysis
NEW Blog Post - Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments
Discovery Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con
Colorectal and Lung Tumoroids are Now Available
NEW Blog Post - Progressing Ex Vivo Gene Editing Innovations with High-Quality Leukopaks
Learn More about Discovery's AI-Annotated FFPE Tissues and DiscoverAI Tissue Analysis
NEW Blog Post - Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments
Discovery Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con